| Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug) | | Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet |
| | Has BoSS | reserpine | | Has precise active ingredient | reserpine | | Has presentation strength denominator unit | Tablet | | Has presentation strength numerator unit | mcg |
|